Last Updated on June 22, 2023

Molecular Cancer- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: BioMed Central Ltd.

Abbreviation: Mol. Cancer




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

28.85

SJR

 8.703

h-Index

 171

Rank

 96

Important Details

Title Molecular Cancer
Standard Abbreviation Mol. Cancer
Type of Publication Journal
Discipline Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1)
Impact Score 28.85
SCImago Journal Rank (SJR) 8.703
h-index 171
Overall Rank 96
Publisher Name BioMed Central Ltd.
Publication Country United Kingdom
International Standard Serial Number (ISSN) 14764598
Coverage and History 2002-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
17050

About Molecular Cancer


Molecular Cancer is a journal published by BioMed Central Ltd.. This journal covers the area[s] related to Cancer Research, Molecular Medicine, Oncology, etc. The coverage history of this journal is as follows: 2002-2022. The rank of this journal is 96. This journal's impact score, h-index, and SJR are 28.85, 171, and 8.703, respectively. The ISSN of this journal is/are as follows: 14764598.

The best quartile of Molecular Cancer is Q1. This journal has received a total of 17050 citations during the last three years (Preceding 2022).


Molecular Cancer Impact Score 2022-2023


The latest impact score (IS) of the Molecular Cancer is 28.85. It is computed in the year 2023 as per its definition and based on Scopus data. 28.85

It is decreased by a factor of around 6.58, and the percentage change is -18.57% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Molecular Cancer Impact Score 2023


Impact Score 2022 of Molecular Cancer is 28.85. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Molecular Cancer. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 28.85
2021 35.43
2020 25.00
2019 15.04
2018 10.82
2017 7.98
2016 6.52
2015 6.35
2014 4.80

Molecular Cancer h-index


  Table Setting

The h-index of Molecular Cancer is 171. By definition of the h-index, this journal has at least 171 published articles with more than 171 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Molecular Cancer ISSN


The International Standard Serial Number (ISSN) of Molecular Cancer is/are as follows: 14764598.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Molecular Cancer Ranking and SCImago Journal Rank (SJR)


The Molecular Cancer is ranked 96 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 8.703.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Molecular Cancer Publisher


Table Setting

The publisher of Molecular Cancer is BioMed Central Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2002-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Molecular Cancer is Mol. Cancer. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Mol. Cancer') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Molecular Cancer


If your area of research or discipline is related to Cancer Research, Molecular Medicine, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Molecular Cancer?

The latest impact score of Molecular Cancer is 28.85. It is computed in the year 2023.


What is the h-index of Molecular Cancer?

The latest h-index of Molecular Cancer is 171. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Molecular Cancer?

The latest SCImago Journal Rank (SJR) of Molecular Cancer is 8.703. It is calculated in the year 2023.


What is the ranking of Molecular Cancer?

The latest ranking of Molecular Cancer is 96. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Molecular Cancer?

Molecular Cancer is published by BioMed Central Ltd.. The publication country of this journal is United Kingdom.


What is the abbreviation of Molecular Cancer?

This standard abbreviation of Molecular Cancer is Mol. Cancer.


Is "Molecular Cancer" a Journal, Conference or Book Series?

Molecular Cancer is a journal published by BioMed Central Ltd..


What is the scope of Molecular Cancer?

The scope of Molecular Cancer is as follows:

  • Cancer Research
  • Molecular Medicine
  • Oncology

For detailed scope of Molecular Cancer, check the official website of this journal.


What is the ISSN of Molecular Cancer?

The International Standard Serial Number (ISSN) of Molecular Cancer is/are as follows: 14764598.


What is the best quartile for Molecular Cancer?

The best quartile for Molecular Cancer is Q1.


What is the coverage history of Molecular Cancer?

The coverage history of Molecular Cancer is as follows 2002-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Proceedings of the ASME Turbo Expo Conference And Proceedings 17577 54 0.00
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
Journal of Geriatric Physical Therapy Journal Lippincott Williams and Wilkins Ltd. 5578 43 1.80
Current Sociology Journal SAGE Publications Ltd 6591 76 2.29
Materials Research Journal Universidade Federal de Sao Carlos 14791 65 1.62
Discourse Journal Routledge 6621 59 2.11
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Sex Education Journal Routledge 5168 41 2.82
Journal of Sociolinguistics Journal Wiley-Blackwell Publishing Ltd 5409 61 1.96
Transnational Corporations Journal UNCTAD United Nations Conference on Trade and Development 6120 27 1.92

Check complete list




Molecular Cancer Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 28.85
2021 35.43
2020 25.00
2019 15.04
2018 10.82
2017 7.98
2016 6.52
2015 6.35
2014 4.80



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

Cancer Immunology Research
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Biomolecular Detection and Quantification
Elsevier GmbH | Germany

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All